12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

Oxford Pharmascience Group, University College London deal

Oxford Pharmascience exercised its option under a deal to license rights from the university to develop and commercialize compounds using Safestat drug delivery technology. Safestat...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >